Inhibition of TGF-β1-induced activation of the Smad2/3 pathway and MAPKs, as well as amelioration of epithelial damage and subepithelial fibrosis in the airways in a mouse model of asthma, were also confirmed [94]. The gene discussed is SMAD2; the disease is asthma.